Quality improvement methods as applied to a multicenter effectiveness trial - STAR*D

Diane Warden, A. John Rush, Madhukar Trivedi, Louise Ritz, Diane Stegman, Stephen R. Wisniewski

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In multicenter clinical trials, important aspects of trial performance (e.g., the number of participants who enter the trial within the required time frame, the number of participants who remain in the trial, and/or the completeness of the outcome data collected) directly affect the extent to which the study can achieve its aims. Obtaining the maximum amount of data from the maximum number of participants at each step in the trial increases the likelihood of identifying real differences in outcome. These aspects of trial performance can, therefore, be considered intermediate performance goals of the study since success in achieving each of them is directly related to success in achieving study aims. A quality improvement system was introduced to improve efficiency and performance in the multicenter Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial. Four intermediate performance goals were targeted for quality improvement efforts: (1) initial enrollment of subjects, (2) collection of entry/exit primary outcome data, (3) retention of subjects to enter subsequent "levels" of the trial, and (4) collection of blood samples for genetics studies. The identification of numerical targets for these goals provides a basis for monitoring performance and for implementing attempts to improve performance, since success in achieving each goal is directly related to success in achieving the study aims. This paper describes the background, rationale, development, and potential utility of implementing a quality improvement system to improve the performance and efficiency of the trial.

Original languageEnglish (US)
Pages (from-to)95-112
Number of pages18
JournalContemporary Clinical Trials
Volume26
Issue number1
DOIs
StatePublished - Feb 2005

Fingerprint

Quality Improvement
Multicenter Studies
Clinical Trials

Keywords

  • Depression
  • Efficiency in clinical trials
  • Improving outcomes collection in clinical trials
  • Improving recruitment and retention in clinical trials
  • Multicenter clinical trials
  • Quality improvement

ASJC Scopus subject areas

  • Pharmacology

Cite this

Quality improvement methods as applied to a multicenter effectiveness trial - STAR*D. / Warden, Diane; Rush, A. John; Trivedi, Madhukar; Ritz, Louise; Stegman, Diane; Wisniewski, Stephen R.

In: Contemporary Clinical Trials, Vol. 26, No. 1, 02.2005, p. 95-112.

Research output: Contribution to journalArticle

Warden, Diane ; Rush, A. John ; Trivedi, Madhukar ; Ritz, Louise ; Stegman, Diane ; Wisniewski, Stephen R. / Quality improvement methods as applied to a multicenter effectiveness trial - STAR*D. In: Contemporary Clinical Trials. 2005 ; Vol. 26, No. 1. pp. 95-112.
@article{53f12b9af28b4ab59d1a24a6421b4619,
title = "Quality improvement methods as applied to a multicenter effectiveness trial - STAR*D",
abstract = "In multicenter clinical trials, important aspects of trial performance (e.g., the number of participants who enter the trial within the required time frame, the number of participants who remain in the trial, and/or the completeness of the outcome data collected) directly affect the extent to which the study can achieve its aims. Obtaining the maximum amount of data from the maximum number of participants at each step in the trial increases the likelihood of identifying real differences in outcome. These aspects of trial performance can, therefore, be considered intermediate performance goals of the study since success in achieving each of them is directly related to success in achieving study aims. A quality improvement system was introduced to improve efficiency and performance in the multicenter Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial. Four intermediate performance goals were targeted for quality improvement efforts: (1) initial enrollment of subjects, (2) collection of entry/exit primary outcome data, (3) retention of subjects to enter subsequent {"}levels{"} of the trial, and (4) collection of blood samples for genetics studies. The identification of numerical targets for these goals provides a basis for monitoring performance and for implementing attempts to improve performance, since success in achieving each goal is directly related to success in achieving the study aims. This paper describes the background, rationale, development, and potential utility of implementing a quality improvement system to improve the performance and efficiency of the trial.",
keywords = "Depression, Efficiency in clinical trials, Improving outcomes collection in clinical trials, Improving recruitment and retention in clinical trials, Multicenter clinical trials, Quality improvement",
author = "Diane Warden and Rush, {A. John} and Madhukar Trivedi and Louise Ritz and Diane Stegman and Wisniewski, {Stephen R.}",
year = "2005",
month = "2",
doi = "10.1016/j.cct.2004.11.011",
language = "English (US)",
volume = "26",
pages = "95--112",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Quality improvement methods as applied to a multicenter effectiveness trial - STAR*D

AU - Warden, Diane

AU - Rush, A. John

AU - Trivedi, Madhukar

AU - Ritz, Louise

AU - Stegman, Diane

AU - Wisniewski, Stephen R.

PY - 2005/2

Y1 - 2005/2

N2 - In multicenter clinical trials, important aspects of trial performance (e.g., the number of participants who enter the trial within the required time frame, the number of participants who remain in the trial, and/or the completeness of the outcome data collected) directly affect the extent to which the study can achieve its aims. Obtaining the maximum amount of data from the maximum number of participants at each step in the trial increases the likelihood of identifying real differences in outcome. These aspects of trial performance can, therefore, be considered intermediate performance goals of the study since success in achieving each of them is directly related to success in achieving study aims. A quality improvement system was introduced to improve efficiency and performance in the multicenter Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial. Four intermediate performance goals were targeted for quality improvement efforts: (1) initial enrollment of subjects, (2) collection of entry/exit primary outcome data, (3) retention of subjects to enter subsequent "levels" of the trial, and (4) collection of blood samples for genetics studies. The identification of numerical targets for these goals provides a basis for monitoring performance and for implementing attempts to improve performance, since success in achieving each goal is directly related to success in achieving the study aims. This paper describes the background, rationale, development, and potential utility of implementing a quality improvement system to improve the performance and efficiency of the trial.

AB - In multicenter clinical trials, important aspects of trial performance (e.g., the number of participants who enter the trial within the required time frame, the number of participants who remain in the trial, and/or the completeness of the outcome data collected) directly affect the extent to which the study can achieve its aims. Obtaining the maximum amount of data from the maximum number of participants at each step in the trial increases the likelihood of identifying real differences in outcome. These aspects of trial performance can, therefore, be considered intermediate performance goals of the study since success in achieving each of them is directly related to success in achieving study aims. A quality improvement system was introduced to improve efficiency and performance in the multicenter Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial. Four intermediate performance goals were targeted for quality improvement efforts: (1) initial enrollment of subjects, (2) collection of entry/exit primary outcome data, (3) retention of subjects to enter subsequent "levels" of the trial, and (4) collection of blood samples for genetics studies. The identification of numerical targets for these goals provides a basis for monitoring performance and for implementing attempts to improve performance, since success in achieving each goal is directly related to success in achieving the study aims. This paper describes the background, rationale, development, and potential utility of implementing a quality improvement system to improve the performance and efficiency of the trial.

KW - Depression

KW - Efficiency in clinical trials

KW - Improving outcomes collection in clinical trials

KW - Improving recruitment and retention in clinical trials

KW - Multicenter clinical trials

KW - Quality improvement

UR - http://www.scopus.com/inward/record.url?scp=17844369733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17844369733&partnerID=8YFLogxK

U2 - 10.1016/j.cct.2004.11.011

DO - 10.1016/j.cct.2004.11.011

M3 - Article

C2 - 15837455

AN - SCOPUS:17844369733

VL - 26

SP - 95

EP - 112

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

IS - 1

ER -